Biologicals

Japanese encephalitis

Proposed revision: Recommendations for Japanese Encephalitis Vaccine (inactivated) for human use

Expert Committee on Biological Standardization, Geneva, 8-12 October 2007

Japanese Encephalitis vaccine, inactivated

Title: Requirements for Japanese Encephalitis Vaccine (Inactivated) for Human Use; Adopted 1987, TRS No 771, Annex 6

Japanese encephalitis vaccine, live attenuated

Title: Guidelines for the production and control of Japanese encephalitis vaccine (live) for human use, Adopted 2000, TRS 910, Annex 3

UPCOMING EVENTS

WHO Drafting Group Meeting on the Revision of TRS 962, Annex 1

(Guidelines to assure the quality, safety and efficacy of recombinant human papillomavirus virus-like particle vaccines) 29-30 April 2014, WHO/HQ, Geneva

Implementation Workshop on Evaluation of Biotherapeutic Products and Evaluation of Similar Biotherapeutic products with emphasis on Monoclonal Antibody Products

13-16 May 2014, Seoul, The Republic of Korea

CONTACTS

Quality, Safety and Standards (QSS)
Immunization, Vaccines and Biologicals (IVB)
World Health Organization (WHO)
Avenue Appia 20
1211 Geneva 27, Switzerland
Fax No. +41 22 7914971